Volumetric-Modulated Arc Therapy: Effective and Efficient End-to-End Patient-Specific Quality Assurance

To explore an effective and efficient end-to-end patient-specific quality-assurance (QA) protocol for volumetric modulated arc radiotherapy (VMAT) and to evaluate the suitability of a stationary radiotherapy QA device (two-dimensional [2D] ion chamber array) for VMAT QA. Three methods were used to a...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of radiation oncology, biology, physics Vol. 82; no. 5; pp. 1567 - 1574
Main Authors O’Daniel, Jennifer, Das, Shiva, Wu, Q. Jackie, Yin, Fang-Fang
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.04.2012
Elsevier
Subjects
Online AccessGet full text
ISSN0360-3016
1879-355X
1879-355X
DOI10.1016/j.ijrobp.2011.01.018

Cover

Abstract To explore an effective and efficient end-to-end patient-specific quality-assurance (QA) protocol for volumetric modulated arc radiotherapy (VMAT) and to evaluate the suitability of a stationary radiotherapy QA device (two-dimensional [2D] ion chamber array) for VMAT QA. Three methods were used to analyze 39 VMAT treatment plans for brain, spine, and prostate: ion chamber (one-dimensional absolute, n = 39), film (2D relative, coronal/sagittal, n = 8), and 2D ion chamber array (ICA, 2D absolute, coronal/sagittal, n = 39) measurements. All measurements were compared with the treatment planning system dose calculation either via gamma analysis (3%, 3- to 4-mm distance-to-agreement criteria) or absolute point dose comparison. The film and ion chamber results were similarly compared with the ICA measurements. Absolute point dose measurements agreed well with treatment planning system computed doses (ion chamber: median deviation, 1.2%, range, −0.6% to 3.3%; ICA: median deviation, 0.6%, range, −1.8% to 2.9%). The relative 2D dose measurements also showed good agreement with computed doses (>93% of pixels in all films passing gamma, >90% of pixels in all ICA measurements passing gamma). The ICA relative dose results were highly similar to those of film (>90% of pixels passing gamma). The coronal and sagittal ICA measurements were statistically indistinguishable by the paired t test with a hypothesized mean difference of 0.1%. The ion chamber and ICA absolute dose measurements showed a similar trend but had disparities of 2-3% in 18% of plans. After validating the new VMAT implementation with ion chamber, film, and ICA, we were able to maintain an effective yet efficient patient-specific VMAT QA protocol by reducing from five (ion chamber, film, and ICA) to two measurements (ion chamber and single ICA) per plan. The ICA (Matrixx®, IBA Dosimetry) was validated for VMAT QA, but ion chamber measurements are recommended for absolute dose comparison until future developments correct the ICA angular dependence.
AbstractList To explore an effective and efficient end-to-end patient-specific quality-assurance (QA) protocol for volumetric modulated arc radiotherapy (VMAT) and to evaluate the suitability of a stationary radiotherapy QA device (two-dimensional [2D] ion chamber array) for VMAT QA.PURPOSETo explore an effective and efficient end-to-end patient-specific quality-assurance (QA) protocol for volumetric modulated arc radiotherapy (VMAT) and to evaluate the suitability of a stationary radiotherapy QA device (two-dimensional [2D] ion chamber array) for VMAT QA.Three methods were used to analyze 39 VMAT treatment plans for brain, spine, and prostate: ion chamber (one-dimensional absolute, n = 39), film (2D relative, coronal/sagittal, n = 8), and 2D ion chamber array (ICA, 2D absolute, coronal/sagittal, n = 39) measurements. All measurements were compared with the treatment planning system dose calculation either via gamma analysis (3%, 3- to 4-mm distance-to-agreement criteria) or absolute point dose comparison. The film and ion chamber results were similarly compared with the ICA measurements.METHODS AND MATERIALSThree methods were used to analyze 39 VMAT treatment plans for brain, spine, and prostate: ion chamber (one-dimensional absolute, n = 39), film (2D relative, coronal/sagittal, n = 8), and 2D ion chamber array (ICA, 2D absolute, coronal/sagittal, n = 39) measurements. All measurements were compared with the treatment planning system dose calculation either via gamma analysis (3%, 3- to 4-mm distance-to-agreement criteria) or absolute point dose comparison. The film and ion chamber results were similarly compared with the ICA measurements.Absolute point dose measurements agreed well with treatment planning system computed doses (ion chamber: median deviation, 1.2%, range, -0.6% to 3.3%; ICA: median deviation, 0.6%, range, -1.8% to 2.9%). The relative 2D dose measurements also showed good agreement with computed doses (>93% of pixels in all films passing gamma, >90% of pixels in all ICA measurements passing gamma). The ICA relative dose results were highly similar to those of film (>90% of pixels passing gamma). The coronal and sagittal ICA measurements were statistically indistinguishable by the paired t test with a hypothesized mean difference of 0.1%. The ion chamber and ICA absolute dose measurements showed a similar trend but had disparities of 2-3% in 18% of plans.RESULTSAbsolute point dose measurements agreed well with treatment planning system computed doses (ion chamber: median deviation, 1.2%, range, -0.6% to 3.3%; ICA: median deviation, 0.6%, range, -1.8% to 2.9%). The relative 2D dose measurements also showed good agreement with computed doses (>93% of pixels in all films passing gamma, >90% of pixels in all ICA measurements passing gamma). The ICA relative dose results were highly similar to those of film (>90% of pixels passing gamma). The coronal and sagittal ICA measurements were statistically indistinguishable by the paired t test with a hypothesized mean difference of 0.1%. The ion chamber and ICA absolute dose measurements showed a similar trend but had disparities of 2-3% in 18% of plans.After validating the new VMAT implementation with ion chamber, film, and ICA, we were able to maintain an effective yet efficient patient-specific VMAT QA protocol by reducing from five (ion chamber, film, and ICA) to two measurements (ion chamber and single ICA) per plan. The ICA (Matrixx®, IBA Dosimetry) was validated for VMAT QA, but ion chamber measurements are recommended for absolute dose comparison until future developments correct the ICA angular dependence.CONCLUSIONSAfter validating the new VMAT implementation with ion chamber, film, and ICA, we were able to maintain an effective yet efficient patient-specific VMAT QA protocol by reducing from five (ion chamber, film, and ICA) to two measurements (ion chamber and single ICA) per plan. The ICA (Matrixx®, IBA Dosimetry) was validated for VMAT QA, but ion chamber measurements are recommended for absolute dose comparison until future developments correct the ICA angular dependence.
To explore an effective and efficient end-to-end patient-specific quality-assurance (QA) protocol for volumetric modulated arc radiotherapy (VMAT) and to evaluate the suitability of a stationary radiotherapy QA device (two-dimensional [2D] ion chamber array) for VMAT QA. Three methods were used to analyze 39 VMAT treatment plans for brain, spine, and prostate: ion chamber (one-dimensional absolute, n = 39), film (2D relative, coronal/sagittal, n = 8), and 2D ion chamber array (ICA, 2D absolute, coronal/sagittal, n = 39) measurements. All measurements were compared with the treatment planning system dose calculation either via gamma analysis (3%, 3- to 4-mm distance-to-agreement criteria) or absolute point dose comparison. The film and ion chamber results were similarly compared with the ICA measurements. Absolute point dose measurements agreed well with treatment planning system computed doses (ion chamber: median deviation, 1.2%, range, −0.6% to 3.3%; ICA: median deviation, 0.6%, range, −1.8% to 2.9%). The relative 2D dose measurements also showed good agreement with computed doses (>93% of pixels in all films passing gamma, >90% of pixels in all ICA measurements passing gamma). The ICA relative dose results were highly similar to those of film (>90% of pixels passing gamma). The coronal and sagittal ICA measurements were statistically indistinguishable by the paired t test with a hypothesized mean difference of 0.1%. The ion chamber and ICA absolute dose measurements showed a similar trend but had disparities of 2-3% in 18% of plans. After validating the new VMAT implementation with ion chamber, film, and ICA, we were able to maintain an effective yet efficient patient-specific VMAT QA protocol by reducing from five (ion chamber, film, and ICA) to two measurements (ion chamber and single ICA) per plan. The ICA (Matrixx®, IBA Dosimetry) was validated for VMAT QA, but ion chamber measurements are recommended for absolute dose comparison until future developments correct the ICA angular dependence.
Purpose To explore an effective and efficient end-to-end patient-specific quality-assurance (QA) protocol for volumetric modulated arc radiotherapy (VMAT) and to evaluate the suitability of a stationary radiotherapy QA device (two-dimensional [2D] ion chamber array) for VMAT QA. Methods and Materials Three methods were used to analyze 39 VMAT treatment plans for brain, spine, and prostate: ion chamber (one-dimensional absolute, n  = 39), film (2D relative, coronal/sagittal, n  = 8), and 2D ion chamber array (ICA, 2D absolute, coronal/sagittal, n  = 39) measurements. All measurements were compared with the treatment planning system dose calculation either via gamma analysis (3%, 3- to 4-mm distance-to-agreement criteria) or absolute point dose comparison. The film and ion chamber results were similarly compared with the ICA measurements. Results Absolute point dose measurements agreed well with treatment planning system computed doses (ion chamber: median deviation, 1.2%, range, −0.6% to 3.3%; ICA: median deviation, 0.6%, range, −1.8% to 2.9%). The relative 2D dose measurements also showed good agreement with computed doses (>93% of pixels in all films passing gamma, >90% of pixels in all ICA measurements passing gamma). The ICA relative dose results were highly similar to those of film (>90% of pixels passing gamma). The coronal and sagittal ICA measurements were statistically indistinguishable by the paired t test with a hypothesized mean difference of 0.1%. The ion chamber and ICA absolute dose measurements showed a similar trend but had disparities of 2-3% in 18% of plans. Conclusions After validating the new VMAT implementation with ion chamber, film, and ICA, we were able to maintain an effective yet efficient patient-specific VMAT QA protocol by reducing from five (ion chamber, film, and ICA) to two measurements (ion chamber and single ICA) per plan. The ICA (Matrixx®, IBA Dosimetry) was validated for VMAT QA, but ion chamber measurements are recommended for absolute dose comparison until future developments correct the ICA angular dependence.
Purpose: To explore an effective and efficient end-to-end patient-specific quality-assurance (QA) protocol for volumetric modulated arc radiotherapy (VMAT) and to evaluate the suitability of a stationary radiotherapy QA device (two-dimensional [2D] ion chamber array) for VMAT QA. Methods and Materials: Three methods were used to analyze 39 VMAT treatment plans for brain, spine, and prostate: ion chamber (one-dimensional absolute, n = 39), film (2D relative, coronal/sagittal, n = 8), and 2D ion chamber array (ICA, 2D absolute, coronal/sagittal, n = 39) measurements. All measurements were compared with the treatment planning system dose calculation either via gamma analysis (3%, 3- to 4-mm distance-to-agreement criteria) or absolute point dose comparison. The film and ion chamber results were similarly compared with the ICA measurements. Results: Absolute point dose measurements agreed well with treatment planning system computed doses (ion chamber: median deviation, 1.2%, range, -0.6% to 3.3%; ICA: median deviation, 0.6%, range, -1.8% to 2.9%). The relative 2D dose measurements also showed good agreement with computed doses (>93% of pixels in all films passing gamma, >90% of pixels in all ICA measurements passing gamma). The ICA relative dose results were highly similar to those of film (>90% of pixels passing gamma). The coronal and sagittal ICA measurements were statistically indistinguishable by the paired t test with a hypothesized mean difference of 0.1%. The ion chamber and ICA absolute dose measurements showed a similar trend but had disparities of 2-3% in 18% of plans. Conclusions: After validating the new VMAT implementation with ion chamber, film, and ICA, we were able to maintain an effective yet efficient patient-specific VMAT QA protocol by reducing from five (ion chamber, film, and ICA) to two measurements (ion chamber and single ICA) per plan. The ICA (Matrixx Registered-Sign , IBA Dosimetry) was validated for VMAT QA, but ion chamber measurements are recommended for absolute dose comparison until future developments correct the ICA angular dependence.
To explore an effective and efficient end-to-end patient-specific quality-assurance (QA) protocol for volumetric modulated arc radiotherapy (VMAT) and to evaluate the suitability of a stationary radiotherapy QA device (two-dimensional [2D] ion chamber array) for VMAT QA. Three methods were used to analyze 39 VMAT treatment plans for brain, spine, and prostate: ion chamber (one-dimensional absolute, n = 39), film (2D relative, coronal/sagittal, n = 8), and 2D ion chamber array (ICA, 2D absolute, coronal/sagittal, n = 39) measurements. All measurements were compared with the treatment planning system dose calculation either via gamma analysis (3%, 3- to 4-mm distance-to-agreement criteria) or absolute point dose comparison. The film and ion chamber results were similarly compared with the ICA measurements. Absolute point dose measurements agreed well with treatment planning system computed doses (ion chamber: median deviation, 1.2%, range, -0.6% to 3.3%; ICA: median deviation, 0.6%, range, -1.8% to 2.9%). The relative 2D dose measurements also showed good agreement with computed doses (>93% of pixels in all films passing gamma, >90% of pixels in all ICA measurements passing gamma). The ICA relative dose results were highly similar to those of film (>90% of pixels passing gamma). The coronal and sagittal ICA measurements were statistically indistinguishable by the paired t test with a hypothesized mean difference of 0.1%. The ion chamber and ICA absolute dose measurements showed a similar trend but had disparities of 2-3% in 18% of plans. After validating the new VMAT implementation with ion chamber, film, and ICA, we were able to maintain an effective yet efficient patient-specific VMAT QA protocol by reducing from five (ion chamber, film, and ICA) to two measurements (ion chamber and single ICA) per plan. The ICA (Matrixx®, IBA Dosimetry) was validated for VMAT QA, but ion chamber measurements are recommended for absolute dose comparison until future developments correct the ICA angular dependence.
Author Wu, Q. Jackie
Das, Shiva
Yin, Fang-Fang
O’Daniel, Jennifer
Author_xml – sequence: 1
  givenname: Jennifer
  surname: O’Daniel
  fullname: O’Daniel, Jennifer
  email: jennifer.odaniel@duke.edu
– sequence: 2
  givenname: Shiva
  surname: Das
  fullname: Das, Shiva
– sequence: 3
  givenname: Q. Jackie
  surname: Wu
  fullname: Wu, Q. Jackie
– sequence: 4
  givenname: Fang-Fang
  surname: Yin
  fullname: Yin, Fang-Fang
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25768427$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21470797$$D View this record in MEDLINE/PubMed
https://www.osti.gov/biblio/22056199$$D View this record in Osti.gov
BookMark eNqVkm1rFDEQx4NU7LX6DUQWRHy1Z5J9yG4R4SjXKlRUWsV3IZvM2qx7yZpkC_ftTdhTQZAiBCYPv5kw__-coCNjDSD0lOA1waR-Naz14Gw3rSkmZI3Tah6gFWlYmxdV9fUIrXBR47yI8DE68X7AOJKsfISOKSkZZi1boW9f7DjvIDgt8_dWzaMIoLKNk9nNLTgx7c-ybd-DDPoOMmFUOmmpwYRsa1QebB5D9lGEdJVfTyB1fM8-zWLUYZ9tvJ-dMBIeo4e9GD08OcRT9Plie3P-Nr_6cPnufHOVy4qykJOqlKzoW6UK1paNILRUVBIsCTRYdKBwI1gdd42kZd_FR1J0dV32tKa4ILQ4Rc-XutYHzb3UAeSttMbEFjiluKpJ20bq5UJNzv6YwQe-017COAoDdva8pW2Fa4ZJJJ8dyLnbgeKT0zvh9vyXghF4cQCEl2LsU7fa_-EqVjclTVy5cNJZ7x30vxGCeTKUD3wxlCdDOU6riWlnf6XFlqLa1gQn9Hhf8pslGaLidxpcEgSiG0q7pIey-n8LyFEbHfv8Dnvwg52diW5ywj3lmF-ngUvzRkgctbLFscDrfxe4__-fUADljg
CODEN IOBPD3
CitedBy_id crossref_primary_10_1016_j_meddos_2013_02_008
crossref_primary_10_1118_1_4816384
crossref_primary_10_1002_mp_16150
crossref_primary_10_1088_1361_6560_ab8955
crossref_primary_10_1120_jacmp_v15i5_4838
crossref_primary_10_1016_j_meddos_2012_10_009
crossref_primary_10_1016_j_ejmp_2019_02_007
crossref_primary_10_1002_acm2_14106
crossref_primary_10_1016_j_canrad_2014_06_009
crossref_primary_10_1016_j_apradiso_2024_111340
crossref_primary_10_1016_j_jrras_2022_01_002
crossref_primary_10_4236_ijmpcero_2013_21003
crossref_primary_10_1002_acm2_13221
crossref_primary_10_1016_j_ejmp_2015_08_011
crossref_primary_10_1016_j_ejmp_2020_12_014
crossref_primary_10_1016_j_radphyschem_2025_112543
crossref_primary_10_1016_j_ejmp_2013_05_004
crossref_primary_10_1118_1_4824433
crossref_primary_10_1016_j_ejmp_2014_01_003
crossref_primary_10_1016_j_ijrobp_2013_03_010
crossref_primary_10_1016_j_meddos_2018_02_008
crossref_primary_10_1016_j_ijrobp_2014_09_008
crossref_primary_10_1118_1_4762682
crossref_primary_10_1002_acm2_13405
crossref_primary_10_1088_2057_1976_aad577
crossref_primary_10_1118_1_4749965
crossref_primary_10_1016_j_radphyschem_2024_111836
crossref_primary_10_1120_jacmp_v13i5_3856
crossref_primary_10_1016_j_ejmp_2018_04_005
crossref_primary_10_1016_j_radonc_2014_01_024
crossref_primary_10_1120_jacmp_v15i5_4843
crossref_primary_10_1088_2057_1976_aa5196
crossref_primary_10_1118_1_4729738
crossref_primary_10_1016_j_ijrobp_2015_07_2271
crossref_primary_10_1016_j_meddos_2018_04_004
crossref_primary_10_1259_bjr_20140577
crossref_primary_10_1120_jacmp_v15i6_4994
Cites_doi 10.1016/S0360-3016(02)02735-9
10.1118/1.597316
10.1016/j.meddos.2003.09.003
10.1088/0031-9155/52/4/023
10.1118/1.598248
10.1016/j.clon.2009.01.014
10.1016/j.ijrobp.2009.05.005
10.1016/S0360-3016(03)00663-1
10.1118/1.1591194
10.1016/j.ijrobp.2009.07.1677
10.1088/0031-9155/40/9/004
10.1002/ijc.1039
10.1088/0031-9155/45/8/309
10.1016/j.radonc.2008.06.013
10.1080/02841860802287116
10.1016/S0360-3016(02)02777-3
10.1016/j.ijrobp.2004.06.253
10.1118/1.3213085
10.1080/02841860802266748
10.1016/j.ijrobp.2004.04.016
10.1016/j.ijrobp.2003.12.008
10.1118/1.2818738
10.1016/j.radonc.2008.12.008
10.1016/j.ijrobp.2008.08.055
10.1016/j.radonc.2008.07.021
10.1016/j.ijrobp.2008.05.060
10.1088/0031-9155/53/19/N01
10.1118/1.3238104
10.1120/jacmp.v8i3.2448
10.1080/02841860802657227
10.1118/1.3190392
10.1088/0031-9155/50/19/017
10.1016/j.ijrobp.2009.03.013
ContentType Journal Article
Copyright 2012 Elsevier Inc.
Elsevier Inc.
2015 INIST-CNRS
Copyright © 2012 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2012 Elsevier Inc.
– notice: Elsevier Inc.
– notice: 2015 INIST-CNRS
– notice: Copyright © 2012 Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
OTOTI
DOI 10.1016/j.ijrobp.2011.01.018
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
OSTI.GOV
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic




MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1879-355X
EndPage 1574
ExternalDocumentID 22056199
21470797
25768427
10_1016_j_ijrobp_2011_01_018
S0360301611001490
1_s2_0_S0360301611001490
Genre Journal Article
GroupedDBID ---
--K
.1-
.FO
0R~
1B1
1P~
1RT
1~5
4.4
457
4G.
53G
5RE
5VS
7-5
AAEDT
AAEDW
AAQFI
AAQQT
AAWTL
AAXUO
ABJNI
ABLJU
ABNEU
ABOCM
ABUDA
ACGFS
ACIUM
ACVFH
ADBBV
ADCNI
ADVLN
AENEX
AEUPX
AEVXI
AFPUW
AFRHN
AFTJW
AHHHB
AIGII
AITUG
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BELOY
DU5
EBS
EFKBS
EJD
F5P
FDB
GBLVA
HED
HMO
HZ~
IHE
J1W
KOM
LX3
M41
MO0
O9-
OC~
OO-
RNS
ROL
RPZ
SDG
SEL
SES
SSZ
UV1
XH2
Z5R
~S-
.55
.GJ
29J
AALRI
AAQXK
ABEFU
ABWVN
ACRPL
ADMUD
ADNMO
ADPAM
AFCTW
AFFNX
AFJKZ
AGRDE
ASPBG
AVWKF
AZFZN
EFJIC
FEDTE
FGOYB
FIRID
G-2
HMK
HVGLF
HX~
NQ-
R2-
RIG
SAE
SEW
UDS
X7M
XPP
ZGI
AAIAV
AGZHU
ALXNB
ZA5
AAYWO
AAYXX
AGQPQ
CITATION
AGCQF
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ABPTK
OTOTI
ID FETCH-LOGICAL-c527t-154c73f9dd37948a124d2c10c1e80abed08a760ab8c24fb4d213b664f26203123
ISSN 0360-3016
1879-355X
IngestDate Fri May 19 00:34:47 EDT 2023
Sat Sep 27 20:31:41 EDT 2025
Mon Jul 21 06:06:38 EDT 2025
Mon Jul 21 09:17:22 EDT 2025
Thu Apr 24 22:57:09 EDT 2025
Wed Oct 01 03:16:31 EDT 2025
Fri Feb 23 02:25:24 EST 2024
Sun Feb 23 10:18:54 EST 2025
Tue Oct 14 19:35:51 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Quality assurance
Ion chamber array
Intensity-modulated arc therapy
Volumetric modulated arc therapy
RapidArc
Human
Conformal radiotherapy
Intensity modulated radiotherapy
Radiobiology
Cancerology
Treatment
Efficiency
Dosimetry
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
Copyright © 2012 Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c527t-154c73f9dd37948a124d2c10c1e80abed08a760ab8c24fb4d213b664f26203123
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 21470797
PQID 929506701
PQPubID 23479
PageCount 8
ParticipantIDs osti_scitechconnect_22056199
proquest_miscellaneous_929506701
pubmed_primary_21470797
pascalfrancis_primary_25768427
crossref_primary_10_1016_j_ijrobp_2011_01_018
crossref_citationtrail_10_1016_j_ijrobp_2011_01_018
elsevier_sciencedirect_doi_10_1016_j_ijrobp_2011_01_018
elsevier_clinicalkeyesjournals_1_s2_0_S0360301611001490
elsevier_clinicalkey_doi_10_1016_j_ijrobp_2011_01_018
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-04-01
PublicationDateYYYYMMDD 2012-04-01
PublicationDate_xml – month: 04
  year: 2012
  text: 2012-04-01
  day: 01
PublicationDecade 2010
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
PublicationTitle International journal of radiation oncology, biology, physics
PublicationTitleAlternate Int J Radiat Oncol Biol Phys
PublicationYear 2012
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References Wong, Chen, Greenland (bib28) 2002; 53
Cotrutz, Kappas, Webb (bib10) 2000; 45
Korreman, Medin, Kjaer-Kristoffersen (bib31) 2009; 48
Ezzell, Burmeister, Dogan (bib5) 2009; 36
Klein, Hanley, Bayouth (bib6) 2009; 36
Bogdanich, Rebelo (bib8) 2001; December 28
Wong, D’Souza, Chen (bib11) 2005; 61
Foglitata, Clivio, Nicolini (bib21) 2008; 89
Bedford, Warrington (bib15) 2009; 73
Duthoy, De Gersem, Vergote (bib29) 2004; 60
Galvin, Ezzell, Eisbrauch (bib3) 2004; 58
Vanetti, Clivio, Nicolini (bib24) 2009; 92
Yu, Li, Ma (bib12) 2002; 53
Beauman, Gete, Chen (bib17) 2004; 29
Yu (bib9) 1995; 40
Kutcher, Coia, Gillin (bib1) 1994; 21
Nelms, Simon (bib36) 2007; 8
Ma, Yu, Earl (bib16) 2001; 96
Shaffer, Nichol, Vollans (bib22) 2010; 76
Duthoy, De Gersem, Vergote (bib27) 2003; 57
Otto (bib13) 2008; 35
Low, Harms, Mutic (bib35) 1998; 25
Kjaer-Kristofferson, Ohlhues, Medin (bib18) 2009; 48
ASTRO/ACR Practice guideline for intensity-modulated radiation therapy (IMRT). 2007. Collaboration of the American College of Radiology (ACR) and the American Society for Therapeutic Radiology and Oncology (ASTRO). Online at
Cozzi, Dinshaw, Shrivastava (bib25) 2008; 89
Bush, Townson, Zavgorodni (bib32) 2008; 53
Yoo, Wu, Lee (bib20) 2010; 76
Wolfsberger, Wagar, Nitsch (bib37) 2010; 11
Johansen, Cozzi, Olsen (bib26) 2009; 48
Schreibmann, Dhabaan, Elder (bib30) 2009; 36
Ezzell, Galvin, Low (bib2) 2003; 30
Bogdanich (bib7) 2010; January 23
.
Shaffer, Morris, Moiseenko (bib19) 2009; 21
Wu, Yoo, Kirkpatrick (bib23) 2009; 75
Herzen, Todorovic, Cremers (bib34) 2007; 52
Ling, Zhang, Archambault (bib14) 2008; 72
Stasi, Giordanengo, Cirio (bib33) 2005; 50
Vanetti (10.1016/j.ijrobp.2011.01.018_bib24) 2009; 92
10.1016/j.ijrobp.2011.01.018_bib4
Ezzell (10.1016/j.ijrobp.2011.01.018_bib2) 2003; 30
Stasi (10.1016/j.ijrobp.2011.01.018_bib33) 2005; 50
Shaffer (10.1016/j.ijrobp.2011.01.018_bib22) 2010; 76
Cotrutz (10.1016/j.ijrobp.2011.01.018_bib10) 2000; 45
Klein (10.1016/j.ijrobp.2011.01.018_bib6) 2009; 36
Bedford (10.1016/j.ijrobp.2011.01.018_bib15) 2009; 73
Korreman (10.1016/j.ijrobp.2011.01.018_bib31) 2009; 48
Ezzell (10.1016/j.ijrobp.2011.01.018_bib5) 2009; 36
Low (10.1016/j.ijrobp.2011.01.018_bib35) 1998; 25
Ling (10.1016/j.ijrobp.2011.01.018_bib14) 2008; 72
Foglitata (10.1016/j.ijrobp.2011.01.018_bib21) 2008; 89
Wu (10.1016/j.ijrobp.2011.01.018_bib23) 2009; 75
Cozzi (10.1016/j.ijrobp.2011.01.018_bib25) 2008; 89
Yu (10.1016/j.ijrobp.2011.01.018_bib12) 2002; 53
Johansen (10.1016/j.ijrobp.2011.01.018_bib26) 2009; 48
Otto (10.1016/j.ijrobp.2011.01.018_bib13) 2008; 35
Schreibmann (10.1016/j.ijrobp.2011.01.018_bib30) 2009; 36
Wolfsberger (10.1016/j.ijrobp.2011.01.018_bib37) 2010; 11
Shaffer (10.1016/j.ijrobp.2011.01.018_bib19) 2009; 21
Bush (10.1016/j.ijrobp.2011.01.018_bib32) 2008; 53
Bogdanich (10.1016/j.ijrobp.2011.01.018_bib8) 2001
Duthoy (10.1016/j.ijrobp.2011.01.018_bib29) 2004; 60
Yoo (10.1016/j.ijrobp.2011.01.018_bib20) 2010; 76
Nelms (10.1016/j.ijrobp.2011.01.018_bib36) 2007; 8
Bogdanich (10.1016/j.ijrobp.2011.01.018_bib7) 2010
Herzen (10.1016/j.ijrobp.2011.01.018_bib34) 2007; 52
Beauman (10.1016/j.ijrobp.2011.01.018_bib17) 2004; 29
Wong (10.1016/j.ijrobp.2011.01.018_bib11) 2005; 61
Kutcher (10.1016/j.ijrobp.2011.01.018_bib1) 1994; 21
Ma (10.1016/j.ijrobp.2011.01.018_bib16) 2001; 96
Yu (10.1016/j.ijrobp.2011.01.018_bib9) 1995; 40
Galvin (10.1016/j.ijrobp.2011.01.018_bib3) 2004; 58
Kjaer-Kristofferson (10.1016/j.ijrobp.2011.01.018_bib18) 2009; 48
Wong (10.1016/j.ijrobp.2011.01.018_bib28) 2002; 53
Duthoy (10.1016/j.ijrobp.2011.01.018_bib27) 2003; 57
References_xml – volume: 48
  start-page: 227
  year: 2009
  end-page: 232
  ident: bib18
  article-title: RapidArc volumetric modulated therapy planning for prostate cancer patients
  publication-title: Acta Oncol
– volume: 76
  start-page: 935
  year: 2010
  end-page: 942
  ident: bib20
  article-title: Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 75
  start-page: 1596
  year: 2009
  end-page: 1604
  ident: bib23
  article-title: Volumetric arc intensity-modulated therapy for spine body radiotherapy: Comparison with static intensity-modulated treatment
  publication-title: Int J Radiat Oncol Biol Phys
– year: 2001; December 28
  ident: bib8
  article-title: A pinpoint beam strays invisibly, harming instead of healing
  publication-title: New York Times
– volume: 89
  start-page: 180
  year: 2008
  end-page: 191
  ident: bib25
  article-title: A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy
  publication-title: Radiother Oncol
– volume: 21
  start-page: 581
  year: 1994
  end-page: 618
  ident: bib1
  article-title: Comprehensive QA for radiation oncology: Report of Task Group No.40 Radiation Therapy Committee
  publication-title: Med Phys
– volume: 96
  start-page: 379
  year: 2001
  end-page: 384
  ident: bib16
  article-title: Optimized intensity-modulated arc therapy for prostate cancer treatment
  publication-title: Int J Cancer
– volume: 52
  start-page: 1197
  year: 2007
  end-page: 1208
  ident: bib34
  article-title: Dosimetric evaluation of a 2D pixel ionization chamber for implementation in clinical routine
  publication-title: Phys Med Biol
– volume: 73
  start-page: 537
  year: 2009
  end-page: 545
  ident: bib15
  article-title: Commissioning of volumetric modulated arc therapy (VMAT)
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 61
  start-page: 830
  year: 2005
  end-page: 841
  ident: bib11
  article-title: Intensity-modulated arc therapy for treatment of high-risk endometrial malignancies
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 21
  start-page: 401
  year: 2009
  end-page: 407
  ident: bib19
  article-title: Volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for simultaneous maximal intraprostatic boost: A planning comparison study
  publication-title: Clin Oncol
– volume: 76
  start-page: 1177
  year: 2010
  end-page: 1184
  ident: bib22
  article-title: A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 36
  start-page: 4530
  year: 2009
  end-page: 4535
  ident: bib30
  article-title: Patient-specific quality assurance for VMAT treatment delivery
  publication-title: Med Phys
– volume: 92
  start-page: 111
  year: 2009
  end-page: 117
  ident: bib24
  article-title: Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx, and larynx: A treatment planning comparison with fixed field IMRT
  publication-title: Radiother Oncol
– volume: 29
  start-page: 18
  year: 2004
  end-page: 25
  ident: bib17
  article-title: Simplified intensity-modulated arc therapy for dose escalated prostate cancer radiotherapy
  publication-title: Med Dosim
– volume: 45
  start-page: 2185
  year: 2000
  end-page: 2206
  ident: bib10
  article-title: Intensity modulated arc therapy (IMAT) with centrally blocked rotational fields
  publication-title: Phys Med Biol
– reference: ASTRO/ACR Practice guideline for intensity-modulated radiation therapy (IMRT). 2007. Collaboration of the American College of Radiology (ACR) and the American Society for Therapeutic Radiology and Oncology (ASTRO). Online at:
– volume: 58
  start-page: 1616
  year: 2004
  end-page: 1634
  ident: bib3
  article-title: Implementing IMRT in clinical practice: A joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 89
  start-page: 254
  year: 2008
  end-page: 262
  ident: bib21
  article-title: Intensity modulation with photons for benign intracranial tumors: A planning comparison of volumetric single arc, helical arc, and fixed gantry techniques
  publication-title: Radiother Oncol
– volume: 36
  start-page: 5359
  year: 2009
  end-page: 5373
  ident: bib5
  article-title: IMRT commissioning: Multiple institution planning and dosimetry comparison, a report from AAPM Task Group 119
  publication-title: Med Phys
– volume: 60
  start-page: 794
  year: 2004
  end-page: 806
  ident: bib29
  article-title: Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer
  publication-title: Int J Radiat Oncol Biol Phys
– year: 2010; January 23
  ident: bib7
  article-title: Radiation offers new cures, and ways to do harm
  publication-title: New York Times
– volume: 53
  start-page: 222
  year: 2002
  end-page: 235
  ident: bib28
  article-title: Intensity-modulated arc therapy simplified
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 11
  start-page: 3057
  year: 2010
  ident: bib37
  article-title: Angular dose dependence of the Matrixx TM and its calibration
  publication-title: J App Clin Med Phys
– volume: 48
  start-page: 185
  year: 2009
  end-page: 191
  ident: bib31
  article-title: Dosimetric verification of RapidArc treatment delivery
  publication-title: Acta Oncol
– reference: .
– volume: 50
  start-page: 4681
  year: 2005
  end-page: 4694
  ident: bib33
  article-title: D-IMRT verification with a 2D pixel ionization chamber: Dosimetric and clinical results in head and neck cancer
  publication-title: Phys Med Biol
– volume: 53
  start-page: N359
  year: 2008
  end-page: N370
  ident: bib32
  article-title: Monte Carlo simulation of RapidArc radiotherapy delivery
  publication-title: Phys Med Biol
– volume: 40
  start-page: 1435
  year: 1995
  end-page: 1449
  ident: bib9
  article-title: Intensity-modulated arc therapy with dynamic multileaf collimation: An alternative to tomotherapy
  publication-title: Phys Med Biol
– volume: 30
  start-page: 2089
  year: 2003
  end-page: 2115
  ident: bib2
  article-title: Guidance document on delivery, treatment planning, and clinical implementation of IMRT: Report of the IMRT subcommittee of the AAPM radiation therapy committee
  publication-title: Med Phys
– volume: 72
  start-page: 575
  year: 2008
  end-page: 581
  ident: bib14
  article-title: Commissioning and quality assurance of RapidArc radiotherapy delivery system
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 8
  start-page: 2448
  year: 2007
  ident: bib36
  article-title: A survey on planar IMRT QA analysis
  publication-title: J Appl Clin Med Phys
– volume: 25
  start-page: 656
  year: 1998
  end-page: 661
  ident: bib35
  article-title: A technique for the quantitative evaluation of dose distributions
  publication-title: Med Phys
– volume: 53
  start-page: 453
  year: 2002
  end-page: 463
  ident: bib12
  article-title: Clinical implementation of intensity-modulated arc therapy
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 57
  start-page: 1019
  year: 2003
  end-page: 1032
  ident: bib27
  article-title: Whole abdominopelvic radiotherapy (WAPRT) using intensity-modulated arc therapy (IMAT): First clinical experience
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 35
  start-page: 310
  year: 2008
  end-page: 317
  ident: bib13
  article-title: Volumetric modulated arc therapy: IMRT in a single gantry arc
  publication-title: Med Phys
– volume: 48
  start-page: 495
  year: 2009
  end-page: 503
  ident: bib26
  article-title: A planning comparison of dose patterns in organs at risk and predicted risk for radiation induced malignancy in the contralateral breast following radiation therapy of primary breast using conventional, IMRT, and volumetric modulated arc treatment techniques
  publication-title: Acta Oncol
– volume: 36
  start-page: 4197
  year: 2009
  end-page: 4212
  ident: bib6
  article-title: Task Group 142 report: Quality assurance for medical accelerators
  publication-title: Med Phys
– ident: 10.1016/j.ijrobp.2011.01.018_bib4
– volume: 53
  start-page: 222
  year: 2002
  ident: 10.1016/j.ijrobp.2011.01.018_bib28
  article-title: Intensity-modulated arc therapy simplified
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/S0360-3016(02)02735-9
– volume: 21
  start-page: 581
  year: 1994
  ident: 10.1016/j.ijrobp.2011.01.018_bib1
  article-title: Comprehensive QA for radiation oncology: Report of Task Group No.40 Radiation Therapy Committee
  publication-title: Med Phys
  doi: 10.1118/1.597316
– volume: 29
  start-page: 18
  year: 2004
  ident: 10.1016/j.ijrobp.2011.01.018_bib17
  article-title: Simplified intensity-modulated arc therapy for dose escalated prostate cancer radiotherapy
  publication-title: Med Dosim
  doi: 10.1016/j.meddos.2003.09.003
– volume: 52
  start-page: 1197
  year: 2007
  ident: 10.1016/j.ijrobp.2011.01.018_bib34
  article-title: Dosimetric evaluation of a 2D pixel ionization chamber for implementation in clinical routine
  publication-title: Phys Med Biol
  doi: 10.1088/0031-9155/52/4/023
– volume: 25
  start-page: 656
  year: 1998
  ident: 10.1016/j.ijrobp.2011.01.018_bib35
  article-title: A technique for the quantitative evaluation of dose distributions
  publication-title: Med Phys
  doi: 10.1118/1.598248
– volume: 21
  start-page: 401
  year: 2009
  ident: 10.1016/j.ijrobp.2011.01.018_bib19
  article-title: Volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for simultaneous maximal intraprostatic boost: A planning comparison study
  publication-title: Clin Oncol
  doi: 10.1016/j.clon.2009.01.014
– volume: 75
  start-page: 1596
  year: 2009
  ident: 10.1016/j.ijrobp.2011.01.018_bib23
  article-title: Volumetric arc intensity-modulated therapy for spine body radiotherapy: Comparison with static intensity-modulated treatment
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2009.05.005
– volume: 57
  start-page: 1019
  year: 2003
  ident: 10.1016/j.ijrobp.2011.01.018_bib27
  article-title: Whole abdominopelvic radiotherapy (WAPRT) using intensity-modulated arc therapy (IMAT): First clinical experience
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/S0360-3016(03)00663-1
– volume: 30
  start-page: 2089
  year: 2003
  ident: 10.1016/j.ijrobp.2011.01.018_bib2
  article-title: Guidance document on delivery, treatment planning, and clinical implementation of IMRT: Report of the IMRT subcommittee of the AAPM radiation therapy committee
  publication-title: Med Phys
  doi: 10.1118/1.1591194
– volume: 76
  start-page: 935
  year: 2010
  ident: 10.1016/j.ijrobp.2011.01.018_bib20
  article-title: Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2009.07.1677
– volume: 40
  start-page: 1435
  year: 1995
  ident: 10.1016/j.ijrobp.2011.01.018_bib9
  article-title: Intensity-modulated arc therapy with dynamic multileaf collimation: An alternative to tomotherapy
  publication-title: Phys Med Biol
  doi: 10.1088/0031-9155/40/9/004
– volume: 96
  start-page: 379
  year: 2001
  ident: 10.1016/j.ijrobp.2011.01.018_bib16
  article-title: Optimized intensity-modulated arc therapy for prostate cancer treatment
  publication-title: Int J Cancer
  doi: 10.1002/ijc.1039
– volume: 45
  start-page: 2185
  year: 2000
  ident: 10.1016/j.ijrobp.2011.01.018_bib10
  article-title: Intensity modulated arc therapy (IMAT) with centrally blocked rotational fields
  publication-title: Phys Med Biol
  doi: 10.1088/0031-9155/45/8/309
– volume: 89
  start-page: 180
  year: 2008
  ident: 10.1016/j.ijrobp.2011.01.018_bib25
  article-title: A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2008.06.013
– volume: 48
  start-page: 185
  year: 2009
  ident: 10.1016/j.ijrobp.2011.01.018_bib31
  article-title: Dosimetric verification of RapidArc treatment delivery
  publication-title: Acta Oncol
  doi: 10.1080/02841860802287116
– volume: 53
  start-page: 453
  year: 2002
  ident: 10.1016/j.ijrobp.2011.01.018_bib12
  article-title: Clinical implementation of intensity-modulated arc therapy
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/S0360-3016(02)02777-3
– volume: 61
  start-page: 830
  year: 2005
  ident: 10.1016/j.ijrobp.2011.01.018_bib11
  article-title: Intensity-modulated arc therapy for treatment of high-risk endometrial malignancies
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2004.06.253
– volume: 36
  start-page: 4530
  year: 2009
  ident: 10.1016/j.ijrobp.2011.01.018_bib30
  article-title: Patient-specific quality assurance for VMAT treatment delivery
  publication-title: Med Phys
  doi: 10.1118/1.3213085
– volume: 48
  start-page: 227
  year: 2009
  ident: 10.1016/j.ijrobp.2011.01.018_bib18
  article-title: RapidArc volumetric modulated therapy planning for prostate cancer patients
  publication-title: Acta Oncol
  doi: 10.1080/02841860802266748
– volume: 60
  start-page: 794
  year: 2004
  ident: 10.1016/j.ijrobp.2011.01.018_bib29
  article-title: Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2004.04.016
– volume: 58
  start-page: 1616
  year: 2004
  ident: 10.1016/j.ijrobp.2011.01.018_bib3
  article-title: Implementing IMRT in clinical practice: A joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2003.12.008
– volume: 35
  start-page: 310
  year: 2008
  ident: 10.1016/j.ijrobp.2011.01.018_bib13
  article-title: Volumetric modulated arc therapy: IMRT in a single gantry arc
  publication-title: Med Phys
  doi: 10.1118/1.2818738
– volume: 92
  start-page: 111
  year: 2009
  ident: 10.1016/j.ijrobp.2011.01.018_bib24
  article-title: Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx, and larynx: A treatment planning comparison with fixed field IMRT
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2008.12.008
– volume: 73
  start-page: 537
  year: 2009
  ident: 10.1016/j.ijrobp.2011.01.018_bib15
  article-title: Commissioning of volumetric modulated arc therapy (VMAT)
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2008.08.055
– volume: 11
  start-page: 3057
  year: 2010
  ident: 10.1016/j.ijrobp.2011.01.018_bib37
  article-title: Angular dose dependence of the Matrixx TM and its calibration
  publication-title: J App Clin Med Phys
– volume: 89
  start-page: 254
  year: 2008
  ident: 10.1016/j.ijrobp.2011.01.018_bib21
  article-title: Intensity modulation with photons for benign intracranial tumors: A planning comparison of volumetric single arc, helical arc, and fixed gantry techniques
  publication-title: Radiother Oncol
  doi: 10.1016/j.radonc.2008.07.021
– volume: 72
  start-page: 575
  year: 2008
  ident: 10.1016/j.ijrobp.2011.01.018_bib14
  article-title: Commissioning and quality assurance of RapidArc radiotherapy delivery system
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2008.05.060
– volume: 53
  start-page: N359
  year: 2008
  ident: 10.1016/j.ijrobp.2011.01.018_bib32
  article-title: Monte Carlo simulation of RapidArc radiotherapy delivery
  publication-title: Phys Med Biol
  doi: 10.1088/0031-9155/53/19/N01
– volume: 36
  start-page: 5359
  year: 2009
  ident: 10.1016/j.ijrobp.2011.01.018_bib5
  article-title: IMRT commissioning: Multiple institution planning and dosimetry comparison, a report from AAPM Task Group 119
  publication-title: Med Phys
  doi: 10.1118/1.3238104
– year: 2001
  ident: 10.1016/j.ijrobp.2011.01.018_bib8
  article-title: A pinpoint beam strays invisibly, harming instead of healing
  publication-title: New York Times
– volume: 8
  start-page: 2448
  year: 2007
  ident: 10.1016/j.ijrobp.2011.01.018_bib36
  article-title: A survey on planar IMRT QA analysis
  publication-title: J Appl Clin Med Phys
  doi: 10.1120/jacmp.v8i3.2448
– volume: 48
  start-page: 495
  year: 2009
  ident: 10.1016/j.ijrobp.2011.01.018_bib26
  publication-title: Acta Oncol
  doi: 10.1080/02841860802657227
– volume: 36
  start-page: 4197
  year: 2009
  ident: 10.1016/j.ijrobp.2011.01.018_bib6
  article-title: Task Group 142 report: Quality assurance for medical accelerators
  publication-title: Med Phys
  doi: 10.1118/1.3190392
– volume: 50
  start-page: 4681
  year: 2005
  ident: 10.1016/j.ijrobp.2011.01.018_bib33
  article-title: D-IMRT verification with a 2D pixel ionization chamber: Dosimetric and clinical results in head and neck cancer
  publication-title: Phys Med Biol
  doi: 10.1088/0031-9155/50/19/017
– volume: 76
  start-page: 1177
  year: 2010
  ident: 10.1016/j.ijrobp.2011.01.018_bib22
  article-title: A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2009.03.013
– year: 2010
  ident: 10.1016/j.ijrobp.2011.01.018_bib7
  article-title: Radiation offers new cures, and ways to do harm
  publication-title: New York Times
SSID ssj0001174
Score 2.2268343
Snippet To explore an effective and efficient end-to-end patient-specific quality-assurance (QA) protocol for volumetric modulated arc radiotherapy (VMAT) and to...
Purpose To explore an effective and efficient end-to-end patient-specific quality-assurance (QA) protocol for volumetric modulated arc radiotherapy (VMAT) and...
Purpose: To explore an effective and efficient end-to-end patient-specific quality-assurance (QA) protocol for volumetric modulated arc radiotherapy (VMAT) and...
SourceID osti
proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1567
SubjectTerms Algorithms
Biological and medical sciences
BRAIN
Brain Neoplasms - radiotherapy
DOSIMETRY
Film Dosimetry - standards
Hematology, Oncology and Palliative Medicine
Humans
Intensity-modulated arc therapy
Ion chamber array
IONIZATION CHAMBERS
Male
Medical sciences
Miscellaneous
PATIENTS
PLANNING
PROSTATE
Prostatic Neoplasms - radiotherapy
QUALITY ASSURANCE
Quality Assurance, Health Care - standards
Quality Control
RADIATION DOSES
Radiology
RADIOLOGY AND NUCLEAR MEDICINE
Radiometry - methods
Radiometry - standards
RADIOTHERAPY
Radiotherapy Dosage
Radiotherapy Planning, Computer-Assisted - methods
Radiotherapy Planning, Computer-Assisted - standards
Radiotherapy, Intensity-Modulated - instrumentation
Radiotherapy, Intensity-Modulated - methods
Radiotherapy, Intensity-Modulated - standards
Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)
RapidArc
Spinal Neoplasms - radiotherapy
VERTEBRAE
Volumetric modulated arc therapy
Title Volumetric-Modulated Arc Therapy: Effective and Efficient End-to-End Patient-Specific Quality Assurance
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0360301611001490
https://www.clinicalkey.es/playcontent/1-s2.0-S0360301611001490
https://dx.doi.org/10.1016/j.ijrobp.2011.01.018
https://www.ncbi.nlm.nih.gov/pubmed/21470797
https://www.proquest.com/docview/929506701
https://www.osti.gov/biblio/22056199
Volume 82
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Baden-Württemberg Complete Freedom Collection (Elsevier)
  customDbUrl:
  eissn: 1879-355X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001174
  issn: 0360-3016
  databaseCode: GBLVA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1879-355X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001174
  issn: 0360-3016
  databaseCode: AKRWK
  dateStart: 19761001
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdKJyFeEN8UxuQHxMvkKd9OeZvQqol9IFgL5clKHGe0gqS0KRL8R_yX3MWOE6BTB1IURW6vaXu_-M7nu98R8hzWFIkbKcU8nsICRSacJZhMlaU89jEtyqnLx87Oo-NJ8HoaTnu9n52spXWVHsgfG-tK_kerMAZ6xSrZf9Cs_VAYgGvQL5xBw3C-lo7f11MLcuyzL2WGjbjAfcTie11VVZM56YQNzA_CELmqGSNw_18VGatKppAnQHOrMqy6xMwhU2n5fR8c6_XSwmLeJr23McQO88QSaQ60A1pIWwSTtvUwOopinXjMs9EV7t00mzZ0XiPs4tPsW2s51jj0dh-JAWYWkR81DcIoKS4ZnrqBDMwIsfkveu6N-ZCB-zPVpmnDmJmwY68DzLAz-8JalG80CzpCMT-YzZdlujDErXjErRlstv7P34jR5PRUjI-m4xeLrwwblOFGvunWcoPseGBAnD7ZOTx59-HEmn1XU37bb9zUadbJhH_f-Co_qF_C1I4ZuskKHtJcd1e5evlTu0HjO-S2Wb_QQw3Gu6Sninvk5pnJ0LhPLjdhkgImqcHkS2oRSQGR1CKStoikfyKSGkRSi8gHZDI6Gr86ZqaZB5OhxysGrrrkfj7MMh9MQJyAX5l50nWkq2InSVXmxAmP4CqWXpCn8KLrp1EU5NgxwQf_6iHpF2WhHhMaSPAW0gCjGU7A8yR2otjPQi4dbCaQ5QPiN3-tkIbpHhuufBZNSuNcaIUIVIhw8IgHhFmphWZ62fL-sNGaaKqYwe4KwNwWOb5JTq3MA7sSrlh5whEX4FxiwCJCVkc3GDpdSeMfa7_3GvfcRVihFFJDS8yhAzEsso_c4XBA9n6Dm_39dTQi8PiA0AZ_AswP7ikmhSrXKwGrqxBL_dwBeaRx2Qq7AdJv8ifbhZ-SW-2MsEv61XKtnoGzX6V75jH7BRA-A8I
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Volumetric-modulated+arc+therapy%3A+effective+and+efficient+end-to-end+patient-specific+quality+assurance&rft.jtitle=International+journal+of+radiation+oncology%2C+biology%2C+physics&rft.au=O%27Daniel%2C+Jennifer&rft.au=Das%2C+Shiva&rft.au=Wu%2C+Q+Jackie&rft.au=Yin%2C+Fang-Fang&rft.date=2012-04-01&rft.issn=1879-355X&rft.eissn=1879-355X&rft.volume=82&rft.issue=5&rft.spage=1567&rft_id=info:doi/10.1016%2Fj.ijrobp.2011.01.018&rft.externalDBID=NO_FULL_TEXT
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F03603016%2FS0360301612X0004X%2Fcov150h.gif